The small GTPase Rac1 is required for smooth muscle contraction

Journal of Physiology

Volumn 592, Issue 5, 2014, Pages 915-926

  Rahman, Awahan ^a   Davis, Benjamin ^a   Lövdahl, Cecilia ^a   Hanumaiah, Veena T ^a   Feil, Robert ^b   Brakebusch, Cord ^c   Arner, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM; CARBACHOL; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PHENYLEPHRINE; PHORBOL DIBUTYRATE; POTASSIUM; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROTEIN KINASE C; RAC1 PROTEIN; THROMBOXANE RECEPTOR;

ANIMAL TISSUE; AORTA; ARTICLE; BLADDER; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; ILEUM; KNOCKOUT MOUSE; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN INTERACTION; SAPHENOUS NERVE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

ANIMALS; CALCIUM SIGNALING; FEMALE; ISOMETRIC CONTRACTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH; NEUROPEPTIDES; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84896703875     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.262998     Document Type: Article

References (49)

1. Arner A, Malmqvist U & Rigler R (1998). Calcium transients and the effect of a photolytically released calcium chelator during electrically induced contractions in rabbit rectococcygeus smooth muscle. Biophys J 75, 1895-1903.
2. Burridge K & Wennerberg K (2004). Rho and Rac take centre stage. Cell 116, 167-179.
3. Bustelo XR (2000). Regulatory and signalling properties of the Vav family. Mol Cell Biol 20, 1461-1477.
4. Cherfils J & Zeghouf M (2013). Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 93, 269-309.
5. Chrostek A, Wu X, Quondamatteo F, Hu R, Sanecka A, Niemann C, Langbein L, Haase I & Brakebusch C (2006). Rac1 is crucial for hair follicle integrity but is not essential for maintenance of the epidermis. Mol Cell Biol 26, 6957-6970.
6. Davis B, Rahman A & Arner A (2012). AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signalling and inhibits NO-induced relaxation. Eur J Pharmacol 695, 88-95.
7. Desire L, Bourdin J, Loiseau N, Peillon H, Picard V, De Oliveira C, Bachelot F, Leblond B, Taverne T, Beausoleil E, Lacombe S, Drouin D & Schweighoffer F (2005). RAC1 inhibition targets amyloid precursor protein processing by γ-secretase and decreases Aβ production in vitro and in vivo. J Biol Chem 280, 37516-37525.
8. Doanes AM, Irani K, Goldschmidt-Clermont PJ & Finkel T (1998). A requirement for rac1 in the PDGF-stimulated migration of fibroblasts and vascular smooth cells. Biochem Mol Biol Int 45, 279-287.
9. Ekman M, Andersson KE & Arner A (2006). Developmental regulation of nerve and receptor mediated contractions of mammalian urinary bladder smooth muscle. Eur J Pharmacol 532, 99-106.
10. Feil S, Valtcheva N & Feil R (2009). Inducible Cre mice. Methods Mol Biol 530, 343-363.
11. Gao Y, Dickerson JB, Guo F, Zheng J & Zheng Y (2004). Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A 101, 7618-7623.
12. Habets GG, van der Kammen RA, Stam JC, Michiels F & Collard JG (1995). Sequence of the human invasion-inducing TIAM1 gene, its conservation in evolution and its expression in tumor cell lines of different tissue origin. Oncogene 10, 1371-1376.
13. Halayko AJ & Solway J (2001). Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol 90, 358-368.
14. Harden TK, Hicks SN & Sondek J (2009). Phospholipase C isozymes as effectors of Ras superfamily GTPases. J. Lipid Res 50 Suppl, S243-S248.
15. Hoover WC, Zhang W, Xue Z, Gao H, Chernoff J, Clapp DW, Gunst SJ & Tepper RS (2012). Inhibition of p21 activated kinase (PAK) reduces airway responsiveness in vivo and in vitro in murine and human airways. PloS One 7, e42601.
16. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M & Narumiya S (2000). Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57, 976-983.
17. Jaffe AB & Hall A (2005). Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21, 247-269.
18. Jezyk MR, Snyder JT, Gershberg S, Worthylake DK, Harden TK & Sondek J (2006). Crystal structure of Rac1 bound to its effector phospholipase C-β2. Nat Struct Mol Biol 13, 1135-1140.
19. Kim KS, Takeda K, Sethi R, Pracyk JB, Tanaka K, Zhou YF, Yu ZX, Ferrans VJ, Bruder JT, Kovesdi I, Irani K, Goldschmidt-Clermont P & Finkel T (1998). Protection from reoxygenation injury by inhibition of rac1. J Clin Invest 101, 1821-1826.
20. 2+. J Biol Chem 264, 5339-5342.
21. Kuhbandner S, Brummer S, Metzger D, Chambon P, Hofmann F & Feil R (2000). Temporally controlled somatic mutagenesis in smooth muscle. Genesis 28, 15-22.
22. Loirand G, Guerin P & Pacaud P (2006). Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98, 322-334.
23. Loirand G & Pacaud P (2010). The role of Rho protein signalling in hypertension. Nat Rev Cardiol 7, 637-647.
24. Lucius C, Arner A, Steusloff A, Troschka M, Hofmann F, Aktories K & Pfitzer G (1998). Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins. J Physiol 506, 83-93.
25. Lyle AN & Griendling KK (2006). Modulation of vascular smooth muscle signalling by reactive oxygen species. Physiology 21, 269-280.
26. McFawn PK, Shen L, Vincent SG, Mak A, Van Eyk JE & Fisher JT (2003). Calcium-independent contraction and sensitization of airway smooth muscle by p21-activated protein kinase. Am J Physiol Lung Cell Mol Physiol 284, L863-L870.
27. 2+ wave and matrix gene expression through phospholipase C in human pulmonary fibroblast. Int J Biochem Cell Biol 45, 1516-1524.
28. 2+ sensitivity in α-toxin permeabilized arterial smooth muscle. Biochem Biophys Res Commun 157, 677-683.
29. Penzes P, Cahill ME, Jones KA & Srivastava DP (2008). Convergent CaMK and RacGEF signals control dendritic structure and function. Trends Cell Biol 18, 405-413.
30. Puetz S, Lubomirov LT & Pfitzer G (2009). Regulation of smooth muscle contraction by small GTPases. Physiology 24, 342-356.
31. i in vasomotion of rat mesenteric small arteries. Cell Calcium 42, 536-547.
32. Rahman A, Ekman M, Shakirova Y, Andersson KE, Morgelin M, Erjefalt JS, Brundin P, Li JY & Sward K (2013). Late onset vascular dysfunction in the R6/1 model of Huntington's disease. Eur J Pharmacol 698, 345-353.
33. Rosenfeldt H, Castellone MD, Randazzo PA & Gutkind JS (2006). Rac inhibits thrombin-induced Rho activation: evidence of a Pak-dependent GTPase crosstalk. J Mol Signal 1, 8.
34. Rossman KL, Der CJ & Sondek J (2005). GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6, 167-180.
35. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA & Collard JG (1999). Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behaviour. J Cell Biol 147, 1009-1022.
36. Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, Lopez-Novoa JM & Bustelo XR (2006). Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 12, 841-845.
37. Sauzeau V, Jerkic M, Lopez-Novoa JM & Bustelo XR (2007). Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Mol Biol Cell 18, 943-952.
38. Sauzeau V, Sevilla MA, Montero MJ & Bustelo XR (2010). The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells. J Clin Invest 120, 315-330.
39. Sawada N, Li Y & Liao JK (2010). Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol 10, 116-121.
40. Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F & Der CJ (2007). Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem 282, 35666-35678.
41. Sjuve R, Arner A, Li Z, Mies B, Paulin D, Schmittner M & Small JV (1998). Mechanical alterations in smooth muscle from mice lacking desmin. J Muscle Res Cell Motil 19, 415-29.
42. i in rat intrapulmonary arteries. J Physiol 571, 147-163.
43. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83, 1325-1358.
44. Takizawa N, Koga Y & Ikebe M (2002). Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. Biochem Biophys Res Commun 297, 773-778.
45. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D & Kirilovsky J (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-15781.
46. 2+-independent contraction of smooth muscle. J Biol Chem 273, 23433-23439.
47. Wirth A, Schroeter M, Kock-Hauser C, Manser E, Chalovich JM, De Lanerolle P & Pfitzer G (2003). Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1. J Physiol 549, 489-500.
48. 2+ currents in cardiac myocytes. Am J Physiol Heart Circ Physiol 288, H650-659.
49. Zhang X & DiSanto ME (2011). Rho-kinase, a common final path of various contractile bladder and ureter stimuli. Handb Exp Pharmacol 202, 543-568.